AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 12c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.37), $0.12 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $10.55 million versus the consensus estimate of $10.35 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Champions Oncology (CSBR) Tops Q1 EPS by 6c
• Lightpath Technologies (LPTH) Misses Q4 EPS by 5c